Health Care & Life Sciences » Pharmaceuticals | Fujian Cosunter Pharmaceutical Co. Ltd.

Fujian Cosunter Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
175,614.40
250,604.00
304,420.30
307,174.30
290,703.00
395,150.80
Cost of Goods Sold (COGS) incl. D&A
27,745.30
38,467.80
39,592.60
42,232.30
41,562.40
75,460.90
Gross Income
147,869.10
212,136.30
264,827.70
264,942.00
249,140.60
319,689.90
SG&A Expense
82,718.60
117,314.90
154,531.40
199,860.70
228,384.90
317,688.50
EBIT
64,062.10
93,630.30
108,199.20
67,796.90
20,755.80
1,560.90
Unusual Expense
-
31.10
-
-
-
-
Non Operating Income/Expense
1,483.40
358.00
417.60
110.80
5,197.10
9,632.10
Interest Expense
52.30
74.90
23.60
46.50
56.60
1,227.90
Pretax Income
67,286.50
98,518.20
121,477.80
78,183.00
37,912.30
15,804.10
Income Tax
10,024.40
14,750.40
17,908.00
8,078.60
1,591.90
4,981.20
Equity in Affiliates
-
-
75.30
3,691.40
2,755.10
4,046
Consolidated Net Income
57,262.20
83,767.90
103,494.60
66,413.00
33,565.30
16,739.30
Net Income
57,262.20
83,767.90
103,494.60
66,413.00
33,565.30
16,484.40
Net Income After Extraordinaries
57,262.20
83,767.90
103,494.60
66,413.00
33,565.30
16,484.40
Net Income Available to Common
57,262.20
83,767.90
103,494.60
66,413.00
33,565.30
16,484.40
EPS (Basic)
0.51
0.75
0.92
0.47
0.24
0.12
Basic Shares Outstanding
149,400.00
149,400.00
111,995.00
141,875.70
140,000.00
140,000
EPS (Diluted)
0.38
0.56
0.92
0.47
0.24
0.12
Diluted Shares Outstanding
149,400.00
149,400.00
111,995.00
141,875.70
140,000.00
140,000
EBITDA
65,782.00
95,703.80
117,222.00
78,687.90
36,259.50
25,359.80
Other Operating Expense
1,088.30
1,191.10
2,097.10
2,715.60
-
440.50
Non-Operating Interest Income
1,109.40
966.10
6,038.30
10,543.30
12,016.10
5,839

About Fujian Cosunter Pharmaceutical Co.

View Profile
Address
Software Park, No. 89
Fuzhou Fujian 350003
China
Employees -
Website http://www.cosunter.com
Updated 07/08/2019
Fujian Cosunter Pharmaceutical Co., Ltd. engages in medical research and development, and the manufacturing and sale of pharmaceutical drugs. Its products include liver-treatment medicine, over-the-counter drugs, common medicine, and cosmetic health care. The company was founded on 28 June 2001, and is headquartered in Fuzhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.